Lupus Research Alliance News
Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

January 27, 2022 NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics (LT) announced two major initiatives to address underrepresentation of minorities in clinical trials and in the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The organization has tackled these […] READ MORE

Shingles Vaccine Recommended for Immunocompromised People

January, 2022 As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the vaccine Shingrix to prevent shingles and its complications in adults 19 years and older whose immune systems are weakened in addition to those adults 50 years and older whose immune systems are not compromised.  Shingrix […] READ MORE

Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis

December 9, 2021 The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia Pharmaceuticals from the AURORA 2 continuation study of Lupkynis™ (voclosporin). These results provide the longest available data for an FDA-approved medicine in lupus nephritis. The U.S. Food and Drug Administration approved Lupkynis arlier this year […] READ MORE

LRA Partnering with NIH, FNIH and Others on Groundbreaking Initiative

December 9, 2021 The Lupus Research Alliance (LRA) is proud and excited to partner again with the National Institutes of Health (NIH), the Foundation for the National Institutes of Health (FNIH), and others on a new program – Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) – that will apply new cutting-edge tools to […] READ MORE

Thanks To NY JETS for Hosting LUPUS AWARENESS DAY November 21

November 22, 2021 The New York Jets and Lupus Research Alliance (LRA) hosted Lupus Awareness Day on November 21, 2021, at MetLife Stadium, with the Jets taking on their division rivals the Miami Dolphins. The event raised awareness of the devastating autoimmune disease and generated over $25,000 for lupus research. The check was accepted by […] READ MORE

2021 Breaking Through Gala

This year the Lupus Research Alliance Breaking Through Gala will take place the evening of Monday, November 22, 2021 both in person and online! So whether you’ll be joining us in New York City at the Ziegfeld Ballroom or watching our live broadcast online, you can support the promising research that is breaking through the […] READ MORE

Pivotal LRA-Funded Research Shared at Annual Rheumatology Meeting

November 15, 2021 The Lupus Research Alliance (LRA) supports research into causes and mechanisms of lupus, and identification of targets supporting the development of new therapies or cures for lupus patients. At this year’s meeting of the American College of Rheumatology (ACR), 17 LRA-funded researchers presented their work to share discoveries with the thousands of […] READ MORE

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2021, November 3-9. Bringing you the most relevant news for our lupus community, following are summaries of key research presented at the meeting: New Data on Approved Lupus Treatments […] READ MORE

LRA’s Marathon Team Life Without Lupus Running Lupus into the Ground!

November 4, 2021 Best of luck and incredible thanks go to our Team Life Without Lupus, who are running the TCS New York City Marathon this Sunday to raise thousands for lupus research.  Disappointed that the 50th anniversary marathon was cancelled in 2020, our runners are even more determined to make this 50th run the most […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates